How can I find out about clinical trials for endostatin?
EntreMed is conducting several Phase I safety studies of endostatin. These trials are nearing completion and limited openings are available. Enrollment in these trials is restricted to patients who live in the same area as the trial center. Patients seeking additional information about these trials should call the University of Wisconsin (Madison) Cancer Connect Line at 1-800-622-8922 or 608-262-5223, or MD Anderson Cancer Center (Houston, Texas) Information line at 1-800-392-1611 (Select Option 3) or 713-792-6161.